Table 2 Patient characteristics
From: Hippocampal EUD in primarily irradiated glioblastoma patients
Frequency | Percentage | ||
|---|---|---|---|
Sex | Male | 36 | 59.0 |
Female | 25 | 41.0 | |
Kind of operation | GTR | 22 | 36.1 |
PE | 37 | 60.7 | |
STR | 2 | 3.3 | |
Temozolomide | Yes | 46 | 75.4 |
No | 15 | 24.6 | |
Karnofsky index | 50 | 3 | 4.9 |
60 | 4 | 6.6 | |
70 | 20 | 32.8 | |
80 | 11 | 18.0 | |
90 | 12 | 19.7 | |
100 | 11 | 18.0 | |
MGMT promoter methylated | Yes | 21 | 34.4 |
No | 31 | 50.8 | |
Partially | 9 | 14.8 | |
IDH1/2 mutated | No data | 5 | 8.2 |
Yes | 4 | 6.6 | |
No | 52 | 85.2 | |
LOH 1p/19q allelic | No data | 10 | 16.4 |
Yes | 2 | 3.3 | |
Only 19q | 4 | 6.6 | |
Only 1p | 3 | 4.9 | |
No | 42 | 68.9 | |
Interuption of temozolomide | No data | 19 | 31.1 |
Yes | 13 | 21.3 | |
No | 29 | 47.5 | |
Age | = < 60 y | 27 | 44.3 |
> 60 y | 34 | 55.7 |